维普期刊资源整合服务平台（V6.5）

161篇 您的检索式：作者名="Small EJ"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma显示文摘	Rini BI Small EJ	2005	J Clin Oncol2005，23，5：	1
2	Suramin therapy for patients with symptomatic hormone-refractory prostate cancer:results of a randomized phase Ⅲ trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone显示文摘	Small EJ Meyer M Marshall ME	2000	J Clin Oncol2000，18，：	1
3	Granulocyte macrophage colony - stimulating factor - secreting allogeneic cellular immunotherapy for hormone - refractory prostate cancer 显示文摘	Small EJ Sacks N Nemunaitis J	2007	Clin Cancer Res2007，13，13：	1
4	Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer:history and rationale显示文摘	RYAN CJ LIN AM SMALL EJ	2006	Urol Oncol2006，24，3：	1
5	Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodiem for the palliation of bone pain in men with metastatic prostate cancer显示文摘	Small EJ Smith MR Seaman JJ	2003	J Clin Oncol2003，21，23：	1
6	Update on chemotherapy for advanced bladder cancer显示文摘	Rosenberg JE Carroll PR Small EJ	2005	J Urol2005，174，：	1
7	The case for secondary hormonal therapies in the chemotherapy age显示文摘	Small EJ Ryan CJ	2006	JUrol2006，176，6：	1
8	Osteoporosis in men treated with androgen deprivation therapy for prostate cancer显示文摘	Ross RW Small EJ	2002	J Urol2002，167，5：	1
9	The mechanism of action of estrogen in castration-resistant prostate cancer: clues from hormone levels显示文摘	Aggarwal R Weinberg V Small EJ Oh W Rushakoff R Ryan CJ	2009	Clin Genitourin Cancer2009，7，3：	1
10	Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment显示文摘	Fong L Small EJ	2008	J Clin Oncol2008，26，：	1
11	Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease显示文摘	Jones S Small BJ	2004	J Int Neuropsychol Soc2004，10，：	1
12	Antiandrogen withdrawal alone or in combination with ketoconazole in androgenindependent prostate cancer patients:a phase Ⅲ trial(CALGB9583)显示文摘	Small EJ Halabi S Dawson NA	2004	J Clin Oncol2004，22，6：	1
13	Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer显示文摘	Halabi S Small EJ Kantoff PW	2003	J Clin Oncol2003，22，7：	1
14	Similar patterns of cognitive deficits in the preclinical phases of vaseular dementia and Alzheimer 's disease显示文摘	Laukka EJ Jones S Small BJ	2004	J Int Neuropsychol Soc2004，10，3：	1
15	Biology and clinical development of vascularendothelial growth factor-targeted therapy in renal cell carcinoma显示文摘	Rini BI Small EJ	2005	J Clin Oncol2005，23，5：	1
16	Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment 显示文摘	Fong L Small EJ	2008	J Clin Oncol2008，26，32：	1
17	Secondary hormonal manipulation of prostate cancer 显示文摘	Small EJ Harris KA	2002	Semin Urol Oncol2002，20，3：	1
18	A pilot trial ofCTLA-4 blockade with human anti-CTLA-4 in patientswith hormone-refractory prostate cancer 显示文摘	Small EJ Tchekmedyian NS Rini BI	2007	Clin CancerRes2007，13，6：	1
19	Infusional floxuridine - based therapy for patients with metastatic renal cell carcinoma显示文摘	Reese DM Corry M Small EJ	2000	Cancer2000，88，6：	1
20	Effect of the somatostatin analog octreotide acetale on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castrationresistant prostate cancer : Results of a phase II study 显示文摘	Friedlander TW Weinberg VK Small EJ	2010	Urol Oncol2010，，：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示